tradingkey.logo

tradingkey.logo
怜玢


Labcorp Holdings Inc

LH
りォッチリストに远加
296.770USD
+5.840+2.01%
終倀 07-24 16:00ET15分遅れの株䟡
24.42B時䟡総額
26.11盎近12ヶ月PER

詳现情報 Labcorp Holdings Inc 䌁業名

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

Labcorp Holdings Incの䌁業情報


䌁業コヌドLH
䌚瀟名Labcorp Holdings Inc
䞊堎日Apr 24, 1991
最高経営責任者「CEO」Schechter (Adam H)
埓業員数70000
蚌刞皮類Ordinary Share
決算期末Apr 24
本瀟所圚地358 S Main St
郜垂BURLINGTON
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United States of America
郵䟿番号27215
電話番号13362291127
りェブサむトhttps://www.labcorp.com/
䌁業コヌドLH
䞊堎日Apr 24, 1991
最高経営責任者「CEO」Schechter (Adam H)

Labcorp Holdings Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
107.23K
-5.50%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
36.49K
+17.78%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
15.04K
+56.95%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
13.74K
--
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
9.85K
+2.92%
Ms. Amy B. Summy
Ms. Amy B. Summy
Executive Vice President, Chief Marketing Officer
Executive Vice President, Chief Marketing Officer
7.88K
+27.39%
Ms. Sandra Dillard van Der Vaart
Ms. Sandra Dillard van Der Vaart
Executive Vice President, Chief Legal Officer, and Corporate Secretary
Executive Vice President, Chief Legal Officer, and Corporate Secretary
5.82K
+62.94%
Ms. Anita Z. Graham
Ms. Anita Z. Graham
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
5.18K
+71.84%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
107.23K
-5.50%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
36.49K
+17.78%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
15.04K
+56.95%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
13.74K
--

よくある質問

Labcorp Holdings Incの䞊䜍5名の株䞻は誰ですか


Labcorp Holdings Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Adam H. Schechter

Labcorp Holdings IncLHの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Labcorp Holdings Incの株匏を保有しおいる機関は1855瀟あり、保有株匏の総垂堎䟡倀は玄88.74Mで、党䜓の108.22%を占めおいたす。2025Q4ず比范しお、機関の持ち株は5570263.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。